Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
Zuzana WalkerFederica GandolfoStefania OriniValentina GaribottoFederica AgostaJavier ArbizuFemke BouwmanAlexander DrzezgaPeter NestorMarina BoccardiDaniele AltomareCristina FestariFlavio Nobilinull nullPublished in: European journal of nuclear medicine and molecular imaging (2018)
Despite widespread use of FDG PET in clinical practice and extensive research, there is still very limited good quality evidence for the use of FDG PET. However, in the opinion of the majority of the panellists, FDG PET is a clinically useful imaging biomarker for idiopathic PD and atypical parkinsonism associated with dementia.